Evidence map›Paper›PMID 24210823›Full record

ArticleCell reports2013

DUB-resistant ubiquitin to survey ubiquitination switches in mammalian cells.

Miklós Békés, Keiji Okamoto, Sarah B Crist, Mathew J Jones, Jessica R Chapman, Bradley B Brasher, Francesco D Melandri, Beatrix M Ueberheide, Eros Lazzerini Denchi, Tony T Huang

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Photocatalytic Diselenide Contraction as a Tool for Site-Selective Isosteric Ubiquitylation.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Resolving the Complexity of Ubiquitin Networks.Frontiers in molecular biosciences · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Miklós BékésDepartment of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
Keiji Okamoto
Sarah B Crist
Mathew J Jones
Jessica R Chapman
Bradley B Brasher
Francesco D Melandri
Beatrix M Ueberheide
Eros Lazzerini Denchi
Tony T Huang
New York University · USBioChem Technology (United States) · USScripps Research Institute · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility PathwayR01GM084244 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUANG, TONY TUNG · 2009 to 2013
$2.3M
The Regulation of DNA Repair by Anchored and Unanchored Ubiquitin ChainsF32GM100598 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BEKES, MIKLOS · 2012 to 2015
$194k
NCI NIH HHS P30 CA016087NIGMS NIH HHS 1F32GM100598NIGMS NIH HHS F32 GM100598NIGMS NIH HHS GM084244NIGMS NIH HHS R01 GM084244
6 · The paper itself

Abstract

The ubiquitin-modification status of proteins in cells is highly dynamic and maintained by specific ligation machineries (E3 ligases) that tag proteins with ubiquitin or by deubiquitinating enzymes (DUBs) that remove the ubiquitin tag. The development of tools that offset this balance is critical in characterizing signaling pathways that utilize such ubiquitination switches. Herein, we generated a DUB-resistant ubiquitin mutant that is recalcitrant to cleavage by various families of DUBs both in vitro and in mammalian cells. As a proof-of-principle experiment, ectopic expression of the uncleavable ubiquitin stabilized monoubiquitinated PCNA in the absence of DNA damage and also revealed a defect in the clearance of the DNA damage response at unprotected telomeres. Importantly, a proteomic survey using the uncleavable ubiquitin identified ubiquitinated substrates, validating the DUB-resistant ubiquitin expression system as a valuable tool for interrogating cell signaling pathways.

Indexed as

Amino Acid SequenceCell Line, TumorDNA DamageHEK293 CellsHumansMolecular Sequence DataProliferating Cell Nuclear AntigenUbiquitinUbiquitinationUbiquitin-Specific ProteasesProliferating Cell Nuclear AntigenUbiquitinUbiquitin-Specific Proteases

Identifiers

PMID24210823
PMCPMC3889155
OpenAlexW2083973084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.